share_log

盘龙药业(002864.SZ)：正在积极推进中药配方颗粒的生产线建设工作，预计在下半年竣工投入生产

Shaanxi Panlong Pharmaceutical (002864.SZ) is actively promoting the construction of the production line for traditional Chinese medicine formula particles, and is expected to be completed and put into production in the second half of the year.

Gelonghui Finance ·  Jun 21 04:05

On June 20, 2024, Shaanxi Panlong Pharmaceutical (002864.SZ) held a roadshow on the expected progress of the traditional Chinese medicine formula granule project and transdermal drug delivery patch research and development. The company replied that it is actively promoting the construction of the production line of traditional Chinese medicine formula granules and expects to be completed and put into production in the second half of the year. While accelerating the construction of the production line, the company is also intensifying the research and development and record-filing work for traditional Chinese medicine formula granules. Currently, the research and development of the company's high barrier transdermal drug delivery system research platform construction project is also proceeding in an orderly process. Information disclosure will be made in a timely manner when milestone progress is achieved in the later stage.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment